Renal fibrosis, a final common pathway of CKD, was significantly reduced in the kidneys of losartan- or metformin-treated Col4a5 G5X Alport syndrome mice compared with control (Fig. 2a,c; MT). This evidence concerns the gene COL4A5 and renal fibrosis.